hotspot -WSS

hotspot

author：focus 2025-10-02 18:50:02 - browse：32871

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： At Orexo, a ‘turning point’ for everything but digital health

WSS

Hospitals need to get ahead of regulations on climate change

Google and Epic fight stronger regulation of AI in health care

Listen: Wegovy in the brain & pivotal Alzheimer's data

WHO calls for emergency meeting on new China virus, as cases spread

Sanders adds drug shortage policies to pandemic preparedness bill

A public scorecard can help hold safety

hotspot

hotspot

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

U.S. death rates show how politics are affecting public health

New air purifier tech could be key to improving indoor air quality

Guardant Health colon cancer test endorsed by FDA advisory panel

Guidelines to prevent youth baseball injuries need more muscle

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Custom gene therapy hints at new path for rare disease treatments

How to save PrEP access — and even expand it

Clinicians often fail to acknowledge the pain caused by long Covid

hotspot

A public scorecard can help hold safety

Why we need mandatory labeling of GMO products

Listen: Wegovy in the brain & pivotal Alzheimer's data

In early work, researchers turn to CRISPR to treat Alzheimer's

U.S. death rates show how politics are affecting public health

Medicare has a new plan to address drug shortages

focus

focus

leisure time

entertainment